Pay in 4 interest-free payments of $5.15 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
This article aims to provide an overview of GLP-1 based drugs, focusing on semaglutide (marketed as Ozempic for type 2 diabetes and as Wegovy for obesity) and tirzepatide (marketed as Mounjaro), which is a dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 agonist
GLP-1s treat diabetes by stimulating insulin secretion after meals, which helps control blood sugar
Finally, the patent protection they hold allows them to set the market price without immediate competition
The Future of Semaglutide: Whats Next
Overview Key Takeaways What Are GLP-1 Medications
By integrating semaglutide into a holistic, healthy lifestyle, individuals can achieve sustainable weight loss, improve their overall well-being, and reduce the risk of obesity-related health complications
US$ 27.66
US$ 22.45
US$ 29.66
US$ 21.92
